Brief: POINT Biopharma Global Says Entered Fourth Amendment To Certain Exclusive Sublicense Agreement

POINT Biopharma Global

12/05/2022 14:18

May 12 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA GLOBAL INC - ENTERED FOURTH AMENDMENT TO
CERTAIN
EXCLUSIVE SUBLICENSE AGREEMENT, DATED APRIL 2, 2020, BETWEEN
POINT & BACH BIOSCIENCES
    * POINT BIOPHARMA GLOBAL - PURSUANT TO AMENDMENT, CO & BACH
BIOSCIENCES TO REMOVE ALL REGULATORY & SALES MILESTONES WHICH
WOULD HAVE BEEN PAYABLE BY CO
    * POINT BIOPHARMA GLOBAL INC - AGREED TO PAY A ONE-TIME
AMENDMENT
FEE TO BACH BIOSCIENCES OF $2 MILLION

Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))